The 8th International Congress on Cutaneous Adverse Drug Reactions, Taiwan, 2013: Focus on Severe Cutaneous Adverse Reactions

被引：7
|
作者：
Dodiuk-Gad, Roni P. [1 ,2 ]
Chung, Wen-Hung [3 ,4 ,5 ,6 ]
Yang, Chih-Hsun [3 ,4 ,5 ,6 ]
Lu, Chun-Wei [3 ,4 ,5 ,6 ]
Hui, Rosaline Chung-Yee [3 ,4 ,5 ,6 ]
Shear, Neil H. [1 ,7 ]
机构：
[1] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Med, Div Dermatol, Toronto, ON, Canada
[2] Haemek Med Ctr, Dept Dermatol, Afula, Israel
[3] Chang Gung Mem Hosp, Dept Dermatol, Drug Hypersensit Clin & Res Ctr, Taipei 10591, Taiwan
[4] Chang Gung Mem Hosp, Dept Dermatol, Drug Hypersensit Clin & Res Ctr, Linkou, Taiwan
[5] Chang Gung Mem Hosp, Dept Dermatol, Drug Hypersensit Clin & Res Ctr, Keelung, Taiwan
[6] Chang Gung Univ, Coll Med, Taoyuan, Taiwan
[7] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Med, Div Clin Pharmacol & Toxicol, Toronto, ON, Canada
来源：
DRUG SAFETY | 2014年 / 37卷 / 06期
关键词：
TOXIC EPIDERMAL NECROLYSIS; STEVENS-JOHNSON-SYNDROME; INDUCED HYPERSENSITIVITY SYNDROME; REACTIVATION; MARKER; CELLS;
D O I：
10.1007/s40264-014-0165-8
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：459 / 464
页数：6
相关论文
共 50 条
  • [1] The 8th International Congress on Cutaneous Adverse Drug Reactions, Taiwan, 2013: Focus on Severe Cutaneous Adverse Reactions
    Roni P. Dodiuk-Gad
    Wen-Hung Chung
    Chih-Hsun Yang
    Chun-Wei Lu
    Rosaline Chung-Yee Hui
    Neil H. Shear
    Drug Safety, 2014, 37 : 459 - 464
  • [2] Severe cutaneous adverse drug reactions
    Chung, Wen-Hung
    Wang, Chuang-Wei
    Dao, Ro-Lan
    JOURNAL OF DERMATOLOGY, 2016, 43 (07) : 758 - 766
  • [3] Immunohistopathological Findings of Severe Cutaneous Adverse Drug Reactions
    Orime, Mari
    JOURNAL OF IMMUNOLOGY RESEARCH, 2017, 2017
  • [4] Approach to Severe Cutaneous Adverse Drug Reactions
    Bellón T.
    Cabañas R.
    González-Herrada C.
    Ramírez E.
    González-Ramos J.
    López San Martín M.
    González-Valle O.
    Fiandor A.M.
    Lerma V.
    Roustan G.
    de Abajo F.
    Current Treatment Options in Allergy, 2017, 4 (2) : 201 - 221
  • [5] Treatment of severe cutaneous adverse drug reactions
    Ingen-Housz-Oro, S.
    Duong, T-A
    de Prost, N.
    Colin, A.
    Fardet, L.
    Lebrun-Vignes, B.
    Barbaud, A.
    Chosidow, O.
    Wolkenstein, P.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2018, 145 (6-7): : 454 - 464
  • [6] Severe cutaneous adverse reactions
    Hung, Shuen-Iu
    Mockenhaupt, Maja
    Blumenthal, Kimberly G.
    Abe, Riichiro
    Ueta, Mayumi
    Ingen-Housz-Oro, Saskia
    Phillips, Elizabeth J.
    Chung, Wen-Hung
    NATURE REVIEWS DISEASE PRIMERS, 2024, 10 (01)
  • [7] Pharmacogenomics of severe cutaneous adverse reactions
    Kaniwa, Nahoko
    Saito, Yoshiro
    PHARMACOGENOMICS, 2013, 14 (06) : 595 - 598
  • [8] Treatments for Severe Cutaneous Adverse Reactions
    Cho, Yung-Tsu
    Chu, Chia-Yu
    JOURNAL OF IMMUNOLOGY RESEARCH, 2017, 2017
  • [9] Cutaneous adverse drug reactions
    Lebrun-Vignes, B.
    Valeyrie-Allanore, L.
    REVUE DE MEDECINE INTERNE, 2015, 36 (04): : 256 - 270
  • [10] Pharmacogenetics of cutaneous adverse drug reactions
    Aihara, Michiko
    JOURNAL OF DERMATOLOGY, 2011, 38 (03) : 246 - 254
12345